Login to Your Account



NeuroSearch Reports Data Slip-Up

Huntington's Drug Snagged on Statistics; Another Trial Needed?

By Jennifer Boggs


Thursday, April 29, 2010
Shares of NeuroSearch A/S sank 30 percent when it turned out the firm's positive Phase III Huntington's disease trial was not quite so positive after all. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription